Louis E Nelsen Iii, MD | |
240 Lucy Dr, Harrisonburg, VA 22801-8036 | |
(540) 438-1314 | |
(540) 438-0797 |
Full Name | Louis E Nelsen Iii |
---|---|
Gender | Male |
Speciality | Obstetrics/gynecology |
Experience | 38 Years |
Location | 240 Lucy Dr, Harrisonburg, Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1487753372 | NPI | - | NPPES |
006204937 | Medicaid | VA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 0101041968 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Augusta Health | Fishersville, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Augusta Medical Group | 3678632544 | 316 |
News Archive
While the world has its eyes on vaccines to stop the spread of coronavirus, therapeutics are still necessary to treat hospitalized patients. One of these treatments, remdesivir, is the first and only antiviral agent of its kind that the U.S. Food and Drug Administration (FDA) has approved so far for COVID-19.
GenSpera, Inc. (OTCBB:GNSZ) announced that Devalingam Mahalingam, MD, PhD, principal investigator of the G-202 Phase II trial in hepatocellular carcinoma, presented final data from the G-202 Phase I clinical trial yesterday at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Boston, MA.
The Prostate Cancer Foundation (PCF) has committed more than $19 million in new research funding for scientific investigations focused on discovering new treatments for recurrent prostate cancer. A total of eight programs representing 18 leading research institutions and 36 researchers were selected as part of the foundation's 2008 Challenge Awards. The funded programs will receive the first of three annual payments, ranging between $500,000 and $1.0 million per program, this week.
Pediatric cardiology experts from around the world will gather at the Indiana University School of Medicine for the inaugural Riley Heart Center Symposium on Cardiac Development Sept. 8-9 at Riley Hospital for Children.
Taking a higher dose of topiramate during the first three months of pregnancy may increase a baby's risk of cleft lip or cleft palate more than when taking a lower dose, according to a study published in the December 27, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.
› Verified 2 days ago
Entity Name | Shenandoah Womens Healthcare |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235112970 PECOS PAC ID: 2163475989 Enrollment ID: O20050222000125 |
News Archive
While the world has its eyes on vaccines to stop the spread of coronavirus, therapeutics are still necessary to treat hospitalized patients. One of these treatments, remdesivir, is the first and only antiviral agent of its kind that the U.S. Food and Drug Administration (FDA) has approved so far for COVID-19.
GenSpera, Inc. (OTCBB:GNSZ) announced that Devalingam Mahalingam, MD, PhD, principal investigator of the G-202 Phase II trial in hepatocellular carcinoma, presented final data from the G-202 Phase I clinical trial yesterday at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Boston, MA.
The Prostate Cancer Foundation (PCF) has committed more than $19 million in new research funding for scientific investigations focused on discovering new treatments for recurrent prostate cancer. A total of eight programs representing 18 leading research institutions and 36 researchers were selected as part of the foundation's 2008 Challenge Awards. The funded programs will receive the first of three annual payments, ranging between $500,000 and $1.0 million per program, this week.
Pediatric cardiology experts from around the world will gather at the Indiana University School of Medicine for the inaugural Riley Heart Center Symposium on Cardiac Development Sept. 8-9 at Riley Hospital for Children.
Taking a higher dose of topiramate during the first three months of pregnancy may increase a baby's risk of cleft lip or cleft palate more than when taking a lower dose, according to a study published in the December 27, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.
› Verified 2 days ago
Entity Name | Augusta Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1245489590 PECOS PAC ID: 3678632544 Enrollment ID: O20081106000590 |
News Archive
While the world has its eyes on vaccines to stop the spread of coronavirus, therapeutics are still necessary to treat hospitalized patients. One of these treatments, remdesivir, is the first and only antiviral agent of its kind that the U.S. Food and Drug Administration (FDA) has approved so far for COVID-19.
GenSpera, Inc. (OTCBB:GNSZ) announced that Devalingam Mahalingam, MD, PhD, principal investigator of the G-202 Phase II trial in hepatocellular carcinoma, presented final data from the G-202 Phase I clinical trial yesterday at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Boston, MA.
The Prostate Cancer Foundation (PCF) has committed more than $19 million in new research funding for scientific investigations focused on discovering new treatments for recurrent prostate cancer. A total of eight programs representing 18 leading research institutions and 36 researchers were selected as part of the foundation's 2008 Challenge Awards. The funded programs will receive the first of three annual payments, ranging between $500,000 and $1.0 million per program, this week.
Pediatric cardiology experts from around the world will gather at the Indiana University School of Medicine for the inaugural Riley Heart Center Symposium on Cardiac Development Sept. 8-9 at Riley Hospital for Children.
Taking a higher dose of topiramate during the first three months of pregnancy may increase a baby's risk of cleft lip or cleft palate more than when taking a lower dose, according to a study published in the December 27, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.
› Verified 2 days ago
Entity Name | Obhg Virginia Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972807394 PECOS PAC ID: 9436323342 Enrollment ID: O20111110000430 |
News Archive
While the world has its eyes on vaccines to stop the spread of coronavirus, therapeutics are still necessary to treat hospitalized patients. One of these treatments, remdesivir, is the first and only antiviral agent of its kind that the U.S. Food and Drug Administration (FDA) has approved so far for COVID-19.
GenSpera, Inc. (OTCBB:GNSZ) announced that Devalingam Mahalingam, MD, PhD, principal investigator of the G-202 Phase II trial in hepatocellular carcinoma, presented final data from the G-202 Phase I clinical trial yesterday at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Boston, MA.
The Prostate Cancer Foundation (PCF) has committed more than $19 million in new research funding for scientific investigations focused on discovering new treatments for recurrent prostate cancer. A total of eight programs representing 18 leading research institutions and 36 researchers were selected as part of the foundation's 2008 Challenge Awards. The funded programs will receive the first of three annual payments, ranging between $500,000 and $1.0 million per program, this week.
Pediatric cardiology experts from around the world will gather at the Indiana University School of Medicine for the inaugural Riley Heart Center Symposium on Cardiac Development Sept. 8-9 at Riley Hospital for Children.
Taking a higher dose of topiramate during the first three months of pregnancy may increase a baby's risk of cleft lip or cleft palate more than when taking a lower dose, according to a study published in the December 27, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Louis E Nelsen Iii, MD Po Box 388, Fishersville, VA 22939-0388 Ph: (540) 438-1314 | Louis E Nelsen Iii, MD 240 Lucy Dr, Harrisonburg, VA 22801-8036 Ph: (540) 438-1314 |
News Archive
While the world has its eyes on vaccines to stop the spread of coronavirus, therapeutics are still necessary to treat hospitalized patients. One of these treatments, remdesivir, is the first and only antiviral agent of its kind that the U.S. Food and Drug Administration (FDA) has approved so far for COVID-19.
GenSpera, Inc. (OTCBB:GNSZ) announced that Devalingam Mahalingam, MD, PhD, principal investigator of the G-202 Phase II trial in hepatocellular carcinoma, presented final data from the G-202 Phase I clinical trial yesterday at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Boston, MA.
The Prostate Cancer Foundation (PCF) has committed more than $19 million in new research funding for scientific investigations focused on discovering new treatments for recurrent prostate cancer. A total of eight programs representing 18 leading research institutions and 36 researchers were selected as part of the foundation's 2008 Challenge Awards. The funded programs will receive the first of three annual payments, ranging between $500,000 and $1.0 million per program, this week.
Pediatric cardiology experts from around the world will gather at the Indiana University School of Medicine for the inaugural Riley Heart Center Symposium on Cardiac Development Sept. 8-9 at Riley Hospital for Children.
Taking a higher dose of topiramate during the first three months of pregnancy may increase a baby's risk of cleft lip or cleft palate more than when taking a lower dose, according to a study published in the December 27, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.
› Verified 2 days ago
Ladene J King, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2291 Evelyn Byrd Ave, Harrisonburg, VA 22801 Phone: 540-434-3831 | |
Dr. M Catherine Slusher, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2291 Evelyn Byrd Ave, Harrisonburg, VA 22801 Phone: 540-434-3831 Fax: 540-432-0518 | |
Dr. C. Larry Whitten, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2291 Evelyn Byrd Ave, Harrisonburg, VA 22801 Phone: 540-434-3831 Fax: 540-432-0518 | |
Sarah C. Mercer, P.A. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2291 Evelyn Byrd Ave, Harrisonburg, VA 22801 Phone: 540-434-3831 Fax: 540-432-0518 | |
Ms. Jennifer M Visger, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 240 Lucy Dr, Harrisonburg, VA 22801 Phone: 540-438-1314 Fax: 540-438-0797 | |
Nicole M Koiner, CNM Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 240 Lucy Dr, Harrisonburg, VA 22801 Phone: 540-438-1314 Fax: 540-438-0797 | |
Kimberly Ann Greer, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 240 Lucy Dr, Harrisonburg, VA 22801 Phone: 540-438-1314 Fax: 540-438-0797 |